{
    "clinical_study": {
        "@rank": "1468", 
        "acronym": "PROOF", 
        "arm_group": [
            {
                "arm_group_label": "Brimonidine tartrate 0.5% gel", 
                "arm_group_type": "Experimental", 
                "description": "once-daily brimonidine tartrate 0.5% gel"
            }, 
            {
                "arm_group_label": "Vehicle", 
                "arm_group_type": "Placebo Comparator", 
                "description": "once-daily brimonidine tartrate vehicle gel"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to evaluate the patient-reported outcomes (feedbacks of\n      patients)of a new drug for the treatment of erythema of rosacea (central facial redness).\n      The feedback of patients receiving the active drug will be compared to the feedback of\n      patients receiving the placebo."
        }, 
        "brief_title": "Patient-Reported Outcome Of Facial Erythema (PROOF)", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Rosacea", 
            "Erythema"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Rosacea", 
                "Erythema"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female subjects age of 18 years or older,\n\n          -  A clinical diagnosis of facial rosacea,\n\n          -  A Patient Self-Assessment score of 4 (severe) at Baseline prior to the study drug\n             application,\n\n          -  A Clinician's Erythema Assessment (CEA) score of 3 (moderate) or 4 (severe) at\n             Baseline prior to the study drug application,\n\n        Exclusion Criteria:\n\n          -  More than 5 facial inflammatory lesions (papules or pustules) of rosacea,\n\n          -  Any uncontrolled chronic or serious disease or medical condition that may either\n             interfere with the interpretation of the clinical trial results, or put the subject\n             at significant risk if the subject participates in the clinical trial as judged by\n             the investigator,\n\n          -  Known or suspected allergies or sensitivities to any component of the study drugs,\n             including the active ingredient brimonidine tartrate (see Investigator's Brochure),\n\n          -  Female who is pregnant or lactating."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01885000", 
            "org_study_id": "RD.03.SPR.29107"
        }, 
        "intervention": [
            {
                "arm_group_label": "Brimonidine tartrate 0.5% gel", 
                "intervention_name": "once-daily brimonidine tartrate 0.5% gel", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Vehicle", 
                "intervention_name": "once-daily brimonidine tartrate vehicle gel", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Brimonidine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 24, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "Klinik f\u00fcr Dermatologie, Venerologie und Allergologie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "D\u00fcsseldorf", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum D\u00fcsseldorf"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt am Main", 
                        "country": "Germany"
                    }, 
                    "name": "Klinikum der Johann Wolfgang Goethe-Universit\u00e4t"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "M\u00fcnster", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum M\u00fcnster, Klinik f\u00fcr Hautkrankheiten"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "T\u00fcbingen", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4ts-Hautklinik Eberhard Karls Universit\u00e4t T\u00fcbingen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuppertal", 
                        "country": "Germany"
                    }, 
                    "name": "Zentrum f\u00fcr Dermatologie, Allergologie und Dermatochirurgie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuppertal", 
                        "country": "Germany"
                    }, 
                    "name": "CentroDerm Gesellschaft f\u00fcr dermatolgische Forschung mbH (GmbH)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lund", 
                        "country": "Sweden"
                    }, 
                    "name": "Capio Citykliniken"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden"
                    }, 
                    "name": "L\u00e4karhuset Odenplan"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dundee", 
                        "country": "United Kingdom", 
                        "zip": "DD1 9SY"
                    }, 
                    "name": "NHS Tayside"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leicester", 
                        "country": "United Kingdom"
                    }, 
                    "name": "University Hospitals of Leicester"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Whipps Cross University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Royal Free Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yorkshire", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Harrogate District Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Sweden: Medical Products Agency"
            ]
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "satisfaction with the overall study treatment", 
            "safety_issue": "No", 
            "time_frame": "Day 8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01885000"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in satisfaction with appearance of facial skin", 
                "time_frame": "Day 8"
            }, 
            {
                "measure": "Change from baseline in mean CEA", 
                "time_frame": "3 hour after drug application"
            }, 
            {
                "measure": "Percentage of subject reporting a treatment-related adverse event", 
                "safety_issue": "Yes", 
                "time_frame": "Throughout the study"
            }
        ], 
        "source": "Galderma", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Galderma", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}